
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1044 | 940 | 1044 | 897 | 1179 | 1813 |
Fund Return | 4.41% | -6.04% | 4.41% | -3.57% | 3.36% | 6.13% |
Place in category | 532 | 635 | 532 | 448 | 283 | 60 |
% in Category | 80 | 88 | 80 | 80 | 61 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Pictet CH Institutional Swiss EquZD | 2.27B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiI | 2.27B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquiP | 2.27B | 8.84 | 1.85 | 7.84 | ||
Pictet CH Institutional Swiss EquiZ | 2.27B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquID | 2.27B | 4.62 | -3.37 | 6.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.71B | 11.69 | 5.78 | 7.07 | ||
Pictet CH Institutional Swiss EquiZ | 2.27B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 2.27B | 8.86 | 2.05 | 8.05 | ||
Pictet CH Institutional Swiss EquZD | 2.27B | 10.09 | 3.81 | 7.80 | ||
Pictet CH Institutional Swiss EquiP | 2.27B | 8.84 | 1.85 | 7.84 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 13.08 | 296.50 | -3.55% | |
Nestle | CH0038863350 | 11.42 | 88.60 | -2.10% | |
Novartis | CH0012005267 | 9.71 | 95.70 | -5.60% | |
ABB | CH0012221716 | 6.06 | 48.85 | +1.35% | |
Richemont | CH0210483332 | 5.50 | 158.35 | -0.06% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Strong Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review